Treatment of acute myeloid leukemia with daunomycin (38 cases)
D'auteuil, P.; Harel, P.
L'Union Medicale du Canada 105(2): 205-210
1976
ISSN/ISBN: 0041-6959 PMID: 1069395 Document Number: 101397
Document emailed within 1 workday
Related Documents
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Nara, N.; Yamashita, Y.; Murohashi, I.; Tanikawa, S.; Imai, Y.; Aoki, N. 1987: Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin Cancer Research 47(9): 2376-2379
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Maynadié, M.; Gerland, L.; Aho, S.; Girodon, Fçois.; Bernier, M.; Brunet, C.; Campos, L.; Daliphard, S.; Deneys, Véronique.; Falkenrodt, A.; Jacob, M-Christine.; Kühlein, E.; LeCalvez, Gève.; Moskovtchenko, P.; Philip, P.; Carli, P-Marie.; Faure, G.C.; Béné, M-Christine. 2002: Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia Haematologica 87(8): 795-803
Sennana Sendi, H.; Elghezal, H.; Temmi, H.; Gribaa, M.; Laatiri, A.èn.; Ben Abid, H.él.; Ben Abdeladhime, A.; Elloumi, M.; Hafsia, A.; Saad, A. 2002: Prognostic impact of karyotype in de novo acute myeloid leukemia: study of 139 cases La Tunisie Medicale 80(9): 531-535
Fagioli, F.; Lanza, F.; Carli, M.G.; Cuneo, A.; Gandini, D.; Del Senno, L.; Castoldi, G. 1990: Immunophenotypic, cytogenetic and molecular investigations in two cases of CALLA positive acute myeloid leukemia Haematologica 75(5): 407-411
Chen, Z.; Chen, J. 2001: Treatment of acute myeloid leukemia in the elderly Zhonghua Nei Ke Za Zhi 40(4): 220-221
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Carneiro, P.C.; Pereira, E.D.; Mitteldorf, C.S.; Martinez, G.A.; Beitler, B.; Pozzi, D.H. 1989: Acute myeloid leukemia after treatment of Hodgkin's disease Revista do Hospital das Clinicas 44(2): 87-90
Nordmann, P.; Schaffner, A.; Dazzi, H. 2000: Cost effectiveness in treatment of acute myeloid leukemia Schweizerische Medizinische Wochenschrift 130(51-52): 1994-2000
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Morikawa, J.; Li, H.; Kim, S.; Nishi, K.; Ueno, S.; Suh, E.; Dougherty, E.; Shmulevich, I.; Shiku, H.; Zhang, W.; Kobayashi, T. 2003: Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha) International Journal of Oncology 23(3): 617-625
Bakhudze, E.V.; Evstigneeva, L.A.; Leenman, E.E.; Klimashevskiĭ, V.F.; Morozova, E.V.; Shashkova, N.G. 2006: Myeloid sarcoma of the uterine cervix as presentation of acute myeloid leukemia Voprosy Onkologii 52(1): 102-104
Promsuwicha, O.; Auewarakul, C.U. 2009: Positive and negative predictive values of HLA-DR and CD34 in the diagnosis of acute promyelocytic leukemia and other types of acute myeloid leukemia with recurrent chromosomal translocations Asian Pacific Journal of Allergy and Immunology 27(4): 209-216
Ramamoorthy, K.; Ramesh, P.; Al Bahar, S. 2008: Primary treatment of acute myeloid leukemia (non M3) in elderly: a review Gulf Journal of Oncology 4: 19-26
Nakayama, S.; Ishikawa, T.; Yabe, H.; Nagai, K.; Kasakura, S.; Uchino, H. 1988: Successful treatment of a patient with acute myeloid leukemia with 1 alpha(OH)D3 Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(6): 1026-1030
Ludescher, C.; Eisterer, W.; Hilbe, W.; Gotwald, M.; Hofmann, J.; Zabernigg, A.; Cianfriglia, M.; Thaler, J. 1995: Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia Leukemia 9(2): 350-356
Shen, Y.; Xue, Y.; Li, J.; Pan, J.; Wu, Y. 2003: Clinical, cytogenetic and dual-color FISH studies on five cases of myelodysplastic syndrome or acute myeloid leukemia patients with 1;7 translocation Chinese Medical Journal 116(2): 231-234
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384